Heartburn Drug

  • GSK Settles Two California Lawsuits Related to Heartburn Drug Zantac

    British drugmaker GSK (GSK.L) announced on Wednesday that it has agreed to settle two lawsuits in California alleging that its discontinued heartburn drug Zantac caused cancer. GSK stated it does not admit to any liability in these settlements. Over the past 12 months, GSK has resolved a series of lawsuits related to Zantac, including several…